Press Releases | DEA.gov
Skip to main content
U.S. flag

An official website of the United States government

Here’s how you know

Dot gov

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Https

Secure .gov websites use HTTPS
A lock ( Lock A locked padlock ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

United States Drug Enforcement Administration

  • Get Updates
  • Scam Alert
  • Full Menu
  • English
  • Español

Main Menu

Explore DEA
  • Who We Are
    • About
    • Mission
    • History
    • Divisions
    • DEA Museum
    • Wall of Honor
    • Contact Us
  • What We Do
    • Forensic Sciences
    • Law Enforcement
    • Education and Prevention
    • Drug Information
    • News
    • Campaigns
  • Careers
    • Special Agent
    • Diversion Investigator
    • Intelligence Research Specialist
    • Forensic Sciences Careers
    • Professional & Administrative Careers
    • Student & Entry Level Careers
    • Employment Eligibility
    • How to Apply
  • Resources
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Data and Statistics
    • FOIA
    • Publications
    • Media Galleries
    • Victim Witness Assistance Program
  • Submit A Tip

Press Releases

Advanced Search

Enter Keywords Below

Filter Results

Select To Narrow Search Results

Year

  • 2025 (2)
  • 2024 (8)
  • 2023 (20)
  • 2022 (31)
  • 2021 (29)
  • 2020 (10)
  • 2019 (29)
  • 2018 (26)

Subject

  • Drug Trafficking (18)
  • Synthetic drugs (18)
  • Seizures (Drugs/Property) (15)
  • Task Forces/Task Force Officers (13)
  • Major Law Enforcement Operation (11)
  • Arrests/Convictions - Major (10)
  • Pharmaceuticals/Pharmacists/Physicians (9)
  • Diversion Division (8)
  • OCDETF/Task Force (8)
  • Prescription Drugs (8)
  • Outreach/Drug Prevention (6)
  • Dark Web- Internet Trafficking (4)
  • Guilty Plea (4)
  • Prevention/Education - DEA websites GSAD, JTT etc (4)
  • Gangs (3)
  • Guns/Weapons (3)
  • Overdose (3)
  • Fake Pills (2)
  • Narcoterrorism (2)
  • Public and Media Affairs - also see Congressional Affairs (2)
  • Asset Forfeiture (1)
  • Intelligence Division - Intelligence Products (1)
  • Money Laundering (1)
  • Press Conferences (1)

Drug Name

  • Fentanyl (267)
  • Methamphetamine (256)
  • Cocaine (246)
  • Heroin (151)
  • Oxycodone (58)
  • Marijuana (Cannabis) (52)
  • Opioids (52)
  • Benzodiazepines (9)
  • Amphetamines (8)
  • Ecstasy/MDMA (5)
  • Morphine (5)
  • Hydromorphone (4)
  • K2/Spice (3)
  • Methadone (3)
  • Ketamine (2)
  • LSD (1)
  • Marijuana Concentrates (1)
  • Synthetic Opioids (28)
  • Steroids (2)

Field Division

  • Washington, DC (21)
  • Headquarters (2)
  • Atlanta (1)
  • Chicago (1)
  • Houston (1)
  • Miami (1)
  • New Jersey (1)
  • New York (1)
Clear All Results
PRESS RELEASE

Member of Southwest Baltimore “NFL” Gang Pleads Guilty to a Federal Racketeering, Distributing Large Quantities of Drugs, Two Murders and an Attempted Murder

December 03, 2021
Greenbelt, Md., – Bobby Cannon, a/k/a Freaky, age 24 of Baltimore, pleaded guilty today to participating in a violent racketeering conspiracy, specifically, the NFL Criminal Enterprise, including committing two murders. The term "NFL" stands for Normandy, Franklin, and Loudon, which are three adjacent streets that run through the Edmondson Village...
December 03, 2021
PRESS RELEASE

Hanover Man Pleads Guilty to Distribution of Fentanyl, Cocaine, and Other Drugs Shipped Through the Mail from California to Maryland

November 22, 2021
Baltimore, Md., – Dwight Antonio Pitts, age 47, of Hanover, Maryland, pleaded guilty on November 19, 2021, to charges related to his participation in a drug distribution conspiracy involving large amounts of fentanyl, cocaine, and other drugs, shipped through the U.S. Mail from California to Maryland. The guilty plea was...
November 22, 2021
PRESS RELEASE

Federal Consent Decree Permanently Bans Baltimore-Based Physician Assistant from Prescribing Opioids and Controlled Substances

November 19, 2021
Baltimore, Md., – U.S. District Judge Deborah L. Boardman has approved a consent decree that permanently enjoins Elizabeth J. Allen, a Baltimore-based physician assistant, from prescribing opioids and other controlled substances, resolving the United States’ civil allegations that Allen violated the Controlled Substances Act (CSA) in illegally prescribing opioids. Under...
November 19, 2021
PRESS RELEASE

Administrator Anne Milgram Remarks on the Overdose Epidemic

November 17, 2021
Thank you and good morning. Thank you to ONDCP and to all the federal partners with whom we have been working on this important issue. This is a critical moment in our country. DEA’s mission is to keep American communities safe and healthy and we are in the midst of...
November 17, 2021
PRESS RELEASE

Ringleader and Members of Multi-State Anabolic Steroid Trafficking Network Sentenced

November 02, 2021
NORFOLK, Va. – Today, a Richmond man was the sixth and final defendant to be sentenced for his role in a multi-state anabolic steroid conspiracy that operated across the country. According to court documents, Clyde Edward Peele, 46, is one of six members of a trafficking network, led by Michael...
November 02, 2021
PRESS RELEASE

25th Operation High Tide Defendant Sentenced for Drug and Gun Crimes

October 12, 2021
NORFOLK, Va. – A Portsmouth man, who was the 25th defendant associated with Operation High Tide, was sentenced today for his role in trafficking firearms and selling heroin. According to court documents, in 2017, Shon E. Melton, 32, of Portsmouth, was attributed with trafficking 19 firearms, including a concealable short...
October 12, 2021
PRESS RELEASE

DEA Issues Public Safety Alert on Sharp Increase in Fake Prescription Pills Containing Fentanyl and Meth

September 27, 2021
Newark, N.J. – Today, the Drug Enforcement Administration issued a Public Safety Alert warning Americans of the alarming increase in the lethality and availability of fake prescription pills containing fentanyl and methamphetamine. DEA’s Public Safety Alert, the first in six years, seeks to raise public awareness of a significant nationwide...
September 27, 2021
PRESS RELEASE

DEA Washington Chief Issues Public Safety Alert: Dangerous Increase in Fake Rx Pills Containing Fentanyl

September 27, 2021
Washington, D.C. – Today, Jarod Forget, Special Agent in Charge of the DEA Washington Division issued a Public Safety Alert warning Maryland, Virginia, and Washington, D.C. residents of the alarming increase in the lethality and availability of fake prescription pills containing fentanyl in our area. This DEA Public Safety Alert...
September 27, 2021
PRESS RELEASE

DEA Issues Public Safety Alert on Sharp Increase in Fake Prescription Pills Containing Fentanyl and Meth

September 27, 2021
WASHINGTON, DC – Today, the Drug Enforcement Administration issued a Public Safety Alert warning Americans of the alarming increase in the lethality and availability of fake prescription pills containing fentanyl and methamphetamine. DEA’s Public Safety Alert, the first in six years, seeks to raise public awareness of a significant nationwide...
September 27, 2021
PRESS RELEASE

DEA Issues Public Safety Alert on Sharp Increase in Fake Prescription Pills Containing Fentanyl and Meth

September 27, 2021
NEW YORK – Today, the Drug Enforcement Administration issued a Public Safety Alert warning Americans of the alarming increase in the lethality and availability of fake prescription pills containing fentanyl and methamphetamine. DEA’s Public Safety Alert, the first in six years, seeks to raise public awareness of a significant nationwide...
September 27, 2021
Showing 1 - 10 of 29 results

Pagination

  • Current page 1
  • Page 2
  • Page 3
  • Next page ›
  • Last page »

SAMHSA Behavioral Health Treatment Locator

  • Who We Are
    • About
    • Domestic Divisions
    • Foreign Offices
    • Contact Us
    • DEA Museum
  • What We Do
    • Forensic Sciences
    • Law Enforcement
    • Drug Prevention
    • Diversion Control Division
    • News
  • Careers
    • Special Agent
    • Diversion Investigator
    • Forensic Sciences
    • Intelligence Research Specialist
    • How to Apply
  • Resources
    • Drug Information
    • Employee Assistance Program
    • FOIA
    • Publications
    • Media Galleries
    • VWAP
  • Doing Business
    with the DEA
    • Overview
    • Current Vendors
    • Prospective Vendors
    • Security Clauses
    • Security Forms
    • Small Business Program
    • Vendor Engagement Request
  • Policies
    • Accessibility & Policy
    • Legal Policies & Disclaimers
    • No FEAR Act
    • Privacy Policy
    • U.S. Department of Justice EEO Policy
    • USA.gov
    • Whistleblower Protection
    • Your Rights as a Federal Employee

United States Drug Enforcement Administration

DEA.gov is an official site of the U.S. Department of Justice
Facebook X LinkedIn Instagram

DEA Contact Center

(202) 307-1000 info@dea.gov
Contact the Webmaster

United States Drug Enforcement Administration

Back
  • Who We Are
  • What We Do
  • Careers
  • Resources
Back
  • About
  • Mission
  • History
  • Divisions
  • DEA Museum
  • Wall of Honor
  • Contact Us
Back
  • Domestic Divisions
  • Foreign Divisions
  • Operational Divisions
Back
  • Submit a Tip
  • Extortion Scam
  • Public Affairs
  • Social Media Directory
Back
  • Forensic Sciences
  • Law Enforcement
  • Education and Prevention
  • Drug Information
  • News
  • Campaigns
Back
  • GUARDS
  • Forensic Sciences Policy
  • Forensic Science Organizations
  • Forensic Science Contact
Back
  • DEA Office of Training
  • El Paso Intelligence Center (EPIC)
  • Intelligence
  • Operations
Back
  • Office of Training Programs
Back
  • Administrative Law Judges
  • DEA Asset Forfeiture
  • Domestic Cannabis Suppression / Eradication Program
  • HIDTA
  • OCDETF
Back
  • Family Summit
  • Red Ribbon
  • Kiki and the History of Red Ribbon Week
  • Red Ribbon Toolkit - Resources For Your Community
  • DEA’s Family Summit
  • Operation Engage
  • Community Outreach
  • Just Think Twice
  • Campus Drug Prevention
  • Get Smart About Drugs
  • Operation Prevention
Back
  • Drug Policy
  • Drug Scheduling
  • The Controlled Substances Act
Back
  • Alerts
  • Press Releases
  • Most Wanted Fugitives
  • Stories
  • Events
  • Speeches
  • Testimony
Back
  • All Fugitives
Back
  • One Pill Can Kill
  • DEA National Prescription Drug Take Back Day
Back
  • Senior Citizens
  • Partner Toolbox
  • Social Media Campaign
Back
  • Special Agent
  • Diversion Investigator
  • Intelligence Research Specialist
  • Forensic Sciences Careers
  • Professional & Administrative Careers
  • Student & Entry Level Careers
  • Employment Eligibility
  • How to Apply
Back
  • Special Agent FAQs
Back
  • Diversion Investigator Job Announcement
Back
  • Intelligence Research Specialist Job Announcements
  • Intelligence Research Specialists FAQs
  • Schedule A Hiring Authority: Intelligence Research Specialist
Back
  • How To Claim Veterans' Preference
  • Priority Consideration
  • Benefits
  • Veterans and People With Disabilities
  • Operation Warfighter
Back
  • Illegal Online Pharmacies
  • OD Justice
  • Fentanyl Supply Chain
  • Pill Press Resources
  • Recovery Resources
  • Together for Families
  • Data and Statistics
  • FOIA
  • Publications
  • Media Galleries
  • Victim Witness Assistance Program
Back
  • Domestic Arrests
  • Staffing and Budget
Back
  • About FOIA
  • Contact DEA FOIA
  • Make a Request
  • What Happens After Making a Request
  • Requester Categories
  • Fees Charged
  • Fee Waiver
  • FOIA FAQ
  • FOIA Logs and Reports
  • FOIA Library
  • Additional FOIA Links
  • FOIA Exemptions
  • What Are Exclusions?
  • Privacy Act
  • Privacy Act Exemptions
  • Privacy Impact Assessment and Management Information Systems
Back
  • Victim Witness Assistance Program Resources
  • Human Trafficking Prevention
  • Submit A Tip +
  • Get Updates
  • Scam Alert
    • English
    • Español